Prescription drug · ANDA
Doxazosin NDC 71335-2395
Doxazosin mesylate 2 mg/1 · Tablet · Oral · Bryant Ranch Prepack
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 71335-2395-1 | 71335239501 | 30 TABLET in 1 BOTTLE (71335-2395-1)Marketed from Apr 29, 2024 | |
| 71335-2395-2 | 71335239502 | 60 TABLET in 1 BOTTLE (71335-2395-2)Marketed from Apr 29, 2024 | |
| 71335-2395-3 | 71335239503 | 90 TABLET in 1 BOTTLE (71335-2395-3)Marketed from Apr 29, 2024 | |
| 71335-2395-4 | 71335239504 | 28 TABLET in 1 BOTTLE (71335-2395-4)Marketed from Apr 29, 2024 | |
| 71335-2395-5 | 71335239505 | 18 TABLET in 1 BOTTLE (71335-2395-5)Marketed from Apr 29, 2024 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Doxazosin
- Generic name (nonproprietary)
- doxazosin
- Active ingredients
- Doxazosin mesylate — 2 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Bryant Ranch Prepack
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 208719
- Marketing start
- Listing expires
- Other FDA classes
- Adrenergic alpha-Antagonists (Mechanism)
- Identifiers
- Product ID 71335-2395_17442115-4aac-79b0-e063-6294a90a84bcSPL ID 17442115-4aac-79b0-e063-6294a90a84bcSPL set ID 6fbb9ca2-e8ca-45c7-a178-b4c8dd7a9a1fRxCUI 197626UNII 86P6PQK0MU
- Pharmacologic class
- alpha-Adrenergic Blocker
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N471335239501followed by a unit qualifier and the quantityPackage 71335-2395-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Label details couldn’t be retrieved right now. Open the label on DailyMed.
Other NDCs under ANDA 208719
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Doxazosin | Doxazosin mesylate 1 mg/1 | TabletOral | Zydus Lifesciences Limited | 70771-1112 |
| Doxazosin | Doxazosin mesylate 2 mg/1 | TabletOral | Zydus Lifesciences Limited | 70771-1113 |
| Doxazosin | Doxazosin mesylate 4 mg/1 | TabletOral | Zydus Lifesciences Limited | 70771-1114 |
| Doxazosin | Doxazosin mesylate 8 mg/1 | TabletOral | Zydus Lifesciences Limited | 70771-1115 |
| Doxazosin | Doxazosin mesylate 8 mg/1 | TabletOral | Aphena Pharma Solutions - Tennessee, LLC | 71610-831 |
| Doxazosin | Doxazosin mesylate 2 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-3965 |
| Doxazosin | Doxazosin mesylate 1 mg/1 | TabletOral | Zydus Pharmaceuticals USA Inc. | 68382-783 |
| Doxazosin | Doxazosin mesylate 2 mg/1 | TabletOral | Zydus Pharmaceuticals USA Inc. | 68382-784 |
| Doxazosin | Doxazosin mesylate 4 mg/1 | TabletOral | Zydus Pharmaceuticals USA Inc. | 68382-785 |
| Doxazosin | Doxazosin mesylate 8 mg/1 | TabletOral | Zydus Pharmaceuticals USA Inc. | 68382-786 |
| Doxazosin | Doxazosin mesylate 4 mg/1 | TabletOral | NuCare Pharmaceuticals,Inc. | 68071-4892 |
| Doxazosin | Doxazosin mesylate 4 mg/1 | TabletOral | A-S Medication Solutions | 50090-3927 |
| Doxazosin | Doxazosin mesylate 2 mg/1 | TabletOral | NuCare Pharmaceuticals, Inc. | 68071-3811 |